FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma

作者: Yu Zhao , Yang Yu , Hengcun Li , Zheng Zhang , Shuilong Guo

DOI: 10.1002/1878-0261.12474

关键词:

摘要: FAM175B is a reported regulator of p53 and suppresses tumorigenesis in numerous types cancer, but very little known about its function esophageal squamous cell carcinomas (ESCCs), almost 70% which exhibit mutations p53. Here, we report that expression downregulated high-grade intraepithelial neoplasia (t = 2.44, P 0.031) ESCC 5.664, < 0.001) tissues relative to adjacent normal tissues. Exogenous cells resulted decrease proliferation rate, inhibition colony formation, an increase apoptosis rate. Knockdown produced the opposite results. Furthermore, confocal microscopy coimmunoprecipitation assay showed Activating transcription factor 4 (ATF4) colocalized interacted with FAM175B. Ubiquitination assays revealed inhibited ubiquitin-dependent ATF4 degradation elevated protein level. Finally, luciferase reporter experiments further clarified promoted CHOP ATF4-dependent manner. Accordingly, proapoptotic activity was significantly rescued by treatment si-ATF4 inhibitor 4-PBA. In summary, ubiquitination p53-independent loss may be early diagnostic biomarker patients.

参考文章(42)
Beverly A. Teicher, Physiologic Mechanisms of Therapeutic Resistance: Blood Flow and Hypoxia Hematology-oncology Clinics of North America. ,vol. 9, pp. 475- 506 ,(1995) , 10.1016/S0889-8588(18)30105-9
Pierre Hainaut, Behnoush Abedi-Ardekani, Cancers of the Upper Gastro-intestinal Tract: A Review of Somatic Mutation Distributions Archives of Iranian Medicine. ,vol. 17, pp. 286- 292 ,(2014)
Tomasz Stokłosa, Jakub Gołab, Prospects for p53-based cancer therapy. Acta Biochimica Polonica. ,vol. 52, pp. 321- 328 ,(2005) , 10.18388/ABP.2005_3445
Katarzyna Szymańska, Pierre Hainaut, TP53 and mutations in human cancer. Acta Biochimica Polonica. ,vol. 50, pp. 231- 238 ,(2003) , 10.18388/ABP.2003_3731
Eric Poe Xing, Chung S. Yang, Yuyang Christine Cai, Guang Yu Yang, Yunlong Song, Yan Nie, Li Dong Wang, Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clinical Cancer Research. ,vol. 5, pp. 2704- 2713 ,(1999)
Eric M. Cooper, Jef D. Boeke, Robert E. Cohen, Specificity of the BRISC Deubiquitinating Enzyme Is Not Due to Selective Binding to Lys63-linked Polyubiquitin Journal of Biological Chemistry. ,vol. 285, pp. 10344- 10352 ,(2010) , 10.1074/JBC.M109.059667
I. Majsterek, A. Slupianek, G. Hoser, T. Skórski, J. Blasiak, ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance? Biochimie. ,vol. 86, pp. 53- 65 ,(2004) , 10.1016/J.BIOCHI.2003.10.008
E Bobrovnikova-Marjon, C Grigoriadou, D Pytel, F Zhang, J Ye, C Koumenis, D Cavener, J A Diehl, PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage Oncogene. ,vol. 29, pp. 3881- 3895 ,(2010) , 10.1038/ONC.2010.153
Lucia Cilenti, Meenakshi P. Balakrishnan, Xiao-Liang Wang, Camilla Ambivero, Martin Sterlicchi, Federica del Monte, Xin L. Ma, Antonis S. Zervos, Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination Journal of Molecular and Cellular Cardiology. ,vol. 50, pp. 652- 661 ,(2011) , 10.1016/J.YJMCC.2010.12.015
Jianhong Zhang, Mengmeng Cao, Jiahong Dong, Changyan Li, Wangxiang Xu, Yiqun Zhan, Xiaohui Wang, Miao Yu, Changhui Ge, Zhiqiang Ge, Xiaoming Yang, ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. Nature Communications. ,vol. 5, pp. 5059- 5059 ,(2014) , 10.1038/NCOMMS6059